SFRP1 and posterior cortical atrophy: We consider that in the future, the evaluation of the co-expression of SFRP1 (stroma) and TMPRSS2-ERG (epithelium) in PCa tumors could help to improve the prognosis and it could make better decisions about pharmacological treatments.